Clinical Quiz: Methotrexate for Pediatric Dermatoses

Methotrexate has been a common treatment for a number of pediatric and adult dermatoses for more than 70 years. An immunosuppressant, there are a number of supporting reasons to incorporate methotrexate into dermatologic care—but there are also pediatric-specific risks and outcomes to be wary of, as well.

In recognition of the Society for Pediatric Dermatology (SPD) 2024 Pre-AAD Meeting in San Diego, CA, this year, this latest HCPLive Clinical Quiz tests readers’ knowledge on the SPD’s recommended management of methotrexate in pediatric patients with conditions including atopic dermatitis, psoriasis, alopecia areata and more. The 5-question quiz is based on recommendations from the SPD’s Patient Perspectives handout, originally published in Pediatric Dermatology in 2023.

How would you fare in treating young patients with acne? Take the quiz below!

What is the most common side effect of methotrexate in children, and how can it be prevented?

Reference

^{Lalor L, Todd P. Society for Pediatric Dermatology. Patient Perspectives: What is methotrexate and how does it work? Pediatric Dermatology: Vol. 40, No. 5 (2023). https://pedsderm.net/site/assets/files/1028/spd_methotrexate_color-1.pdf}